Antithymocyte globulin and cyclosporine for treatment of 44 children with hepatitis associated aplastic anemia.
We analyzed the outcomes of 44 children with hepatitis associated aplastic anemia (HAA) who received immunosuppressive therapy (IST) with antithymocyte globulin (ATG) and cyclosporine (CsA). Fourteen (31.8%) patients achieved complete response and 17 (38.6%) achieved partial response, for an overall response rate of 70.4% after 6 months. Seven non-responders received bone marrow transplantation from an HLA-matched unrelated donor and 6 out of 7 are alive. The probability of overall survival at 10 years was 88.3+/-4.9%, which supports the role of IST with ATG and CsA as treatment of choice for children with HAA without an HLA identical sibling donor.
Osugi
Yuko
Y
Dept. of Pediatrics, Osaka General Medical Center, Osaka, Japan.
Yagasaki
Hiroshi
H
Sako
Masahiro
M
Kosaka
Yoshiyuki
Y
Taga
Takashi
T
Ito
Tsuyoshi
T
Yamamoto
Masuji
M
Ohara
Akira
A
Sato
Takeyuki
T
Mimaya
Junichi
J
Tsukimoto
Ichiro
I
Kojima
Seiji
S
D000293:Adolescent; D000741:Anemia, Aplastic / Q000401:mortality / Q000628:therapy*; D000961:Antilymphocyte Serum / Q000008:administration & dosage*; D016026:Bone Marrow Transplantation; D002648:Child; D002675:Child, Preschool; D016572:Cyclosporine / Q000008:administration & dosage*; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006505:Hepatitis / Q000473:pathology / Q000628:therapy*; D006650:Histocompatibility Testing; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D007223:Infant; D008297:Male; D015996:Survival Rate; D014184:Transplantation, Homologous
D000961:Antilymphocyte Serum; D007166:Immunosuppressive Agents; D016572:Cyclosporine